These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9521654)

  • 1. Mutational analysis of the P-glycoprotein first intracellular loop and flanking transmembrane domains.
    Kwan T; Gros P
    Biochemistry; 1998 Mar; 37(10):3337-50. PubMed ID: 9521654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket.
    Loo TW; Bartlett MC; Clarke DM
    Biochem J; 2006 Oct; 399(2):351-9. PubMed ID: 16813563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.
    Hrycyna CA; Airan LE; Germann UA; Ambudkar SV; Pastan I; Gottesman MM
    Biochemistry; 1998 Sep; 37(39):13660-73. PubMed ID: 9753453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of chemical chaperones in the yeast Saccharomyces cerevisiae to enhance heterologous membrane protein expression: high-yield expression and purification of human P-glycoprotein.
    Figler RA; Omote H; Nakamoto RK; Al-Shawi MK
    Arch Biochem Biophys; 2000 Apr; 376(1):34-46. PubMed ID: 10729188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenesis of transmembrane domain 11 of P-glycoprotein by alanine scanning.
    Hanna M; Brault M; Kwan T; Kast C; Gros P
    Biochemistry; 1996 Mar; 35(11):3625-35. PubMed ID: 8639515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative structure--activity relationship analysis and molecular dynamics simulation to functionally validate nonsynonymous polymorphisms of human ABC transporter ABCB1 (P-glycoprotein/MDR1).
    Sakurai A; Onishi Y; Hirano H; Seigneuret M; Obanayama K; Kim G; Liew EL; Sakaeda T; Yoshiura K; Niikawa N; Sakurai M; Ishikawa T
    Biochemistry; 2007 Jul; 46(26):7678-93. PubMed ID: 17559192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A key structural domain of the Candida albicans Mdr1 protein.
    Mandal A; Kumar A; Singh A; Lynn AM; Kapoor K; Prasad R
    Biochem J; 2012 Aug; 445(3):313-22. PubMed ID: 22587419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide binding, ATP hydrolysis, and mutation of the catalytic carboxylates of human P-glycoprotein cause distinct conformational changes in the transmembrane segments.
    Loo TW; Bartlett MC; Clarke DM
    Biochemistry; 2007 Aug; 46(32):9328-36. PubMed ID: 17636884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid residues important for substrate specificity of the amino acid permeases Can1p and Gnp1p in Saccharomyces cerevisiae.
    Regenberg B; Kielland-Brandt MC
    Yeast; 2001 Nov; 18(15):1429-40. PubMed ID: 11746604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the nucleotide-binding sites of P-glycoprotein that affect substrate specificity modulate substrate-induced adenosine triphosphatase activity.
    Beaudet L; Urbatsch IL; Gros P
    Biochemistry; 1998 Jun; 37(25):9073-82. PubMed ID: 9636053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Rad51 amino acid residues required for Rad52 binding.
    Kurumizaka H; Aihara H; Kagawa W; Shibata T; Yokoyama S
    J Mol Biol; 1999 Aug; 291(3):537-48. PubMed ID: 10448035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The glycosylation and orientation in the membrane of the third cytoplasmic loop of human P-glycoprotein is affected by mutations and substrates.
    Loo TW; Clarke DM
    Biochemistry; 1999 Apr; 38(16):5124-9. PubMed ID: 10213617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the karmellae-inducing signal in Hmg1p, a yeast HMG-CoA reductase isozyme.
    Profant DA; Roberts CJ; Wright RL
    Yeast; 2000 Jun; 16(9):811-27. PubMed ID: 10861905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein in intestines, liver, kidney and lymphocytes in horse.
    Tydén E; Tallkvist J; Tjälve H; Larsson P
    J Vet Pharmacol Ther; 2009 Apr; 32(2):167-76. PubMed ID: 19290947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-glycoprotein: from genomics to mechanism.
    Ambudkar SV; Kimchi-Sarfaty C; Sauna ZE; Gottesman MM
    Oncogene; 2003 Oct; 22(47):7468-85. PubMed ID: 14576852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenic mapping of helical structures in the transmembrane segments of the yeast alpha-factor receptor.
    Martin NP; Celić A; Dumont ME
    J Mol Biol; 2002 Apr; 317(5):765-88. PubMed ID: 11955023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux.
    Tainton KM; Smyth MJ; Jackson JT; Tanner JE; Cerruti L; Jane SM; Darcy PK; Johnstone RW
    Cell Death Differ; 2004 Sep; 11(9):1028-37. PubMed ID: 15131592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The W232R suppressor mutation promotes maturation of a truncation mutant lacking both nucleotide-binding domains and restores interdomain assembly and activity of P-glycoprotein processing mutants.
    Loo TW; Bartlett MC; Clarke DM
    Biochemistry; 2011 Feb; 50(5):672-85. PubMed ID: 21182301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do drug substrates enter the common drug-binding pocket of P-glycoprotein through "gates"?
    Loo TW; Clarke DM
    Biochem Biophys Res Commun; 2005 Apr; 329(2):419-22. PubMed ID: 15737603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for altered ion transport in Saccharomyces cerevisiae overexpressing human MDR 1 protein.
    Fritz F; Howard EM; Hoffman MM; Roepe PD
    Biochemistry; 1999 Mar; 38(13):4214-26. PubMed ID: 10194338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.